Biomarkers of Cardiac Health and Disease

Area of Science:

• Biochemistry
• Cardiology
• Molecular Diagnostics

Background:

• Cardiovascular diseases (CVDs) are a leading cause of global morbidity and mortality.
• Current diagnostic methods like clinical assessment and electrocardiograms lack sufficient sensitivity and specificity.
• The diverse and often asymptomatic nature of CVDs necessitates improved diagnostic tools.

Purpose of the Study:

• To review potential biomolecules for the confirmatory diagnosis of cardiovascular diseases.
• To highlight biomarkers that can indicate the presence of various CVDs and overall cardiac health status.
• To address the need for early and accurate detection of CVDs for effective clinical management.

Main Methods:

• Literature review of existing studies on CVD biomarkers.
• Analysis of biomolecules with potential diagnostic value for different cardiovascular conditions.
• Evaluation of the clinical applicability and limitations of current and emerging biomarkers.

Main Results:

• Existing diagnostic parameters for CVDs exhibit limitations in sensitivity and specificity.
• Numerous biomolecules show promise but are not yet widely used in clinical practice for CVD diagnosis.
• A single biomarker is often insufficient for early-stage or definitive diagnosis.

Conclusions:

• There is a critical need for novel, sensitive, and specific biomarkers for early CVD detection.
• Further research and validation are required to translate promising biomolecules into routine clinical diagnostics.
• Developing effective biomarker strategies is essential for improving patient outcomes in cardiovascular medicine.